comparemela.com

Latest Breaking News On - டிக்கின்சன் மற்றும் நிறுவனம் - Page 3 : comparemela.com

Outlook on the Healthcare-Acquired Infection Global Market to 2026 - Key Factors Driving Opportunities

Outlook on the Healthcare-Acquired Infection Global Market to 2026 - Key Factors Driving Opportunities
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Mexico
Australia
Japan
United-states
New-zealand
India
China
Canada
Russia
Dublin
Ireland
America

Global Blood Screening Markets Report 2021-2027: Technological Advancements & Increasing Number of Blood Donations and Transfusion Related Screenings

Global Blood Screening Markets Report 2021-2027: Technological Advancements & Increasing Number of Blood Donations and Transfusion Related Screenings
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Japan
Canada
France
Switzerland
Laura-wood
Biovision-inc
Origene-technologies-inc
Laboratories-co
Strategic-development
Roche-ltd
Boster-biological-technology
Office-hours-call

Global In Vitro Diagnostics (IVD) Quality Control Industry (2020 to 2027) - Market Trajectory & Analytics

/PRNewswire/ The "In Vitro Diagnostics (IVD) Quality Control - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com s.

Australia
Japan
United-states
United-kingdom
Argentina
Brazil
China
Canada
Russia
Dublin
Ireland
Mexico

$926.6 Million Worldwide In Vitro Diagnostics (IVD) Quality Control Industry to 2027 - Impact of COVID-19 on the Market

Share: ResearchAndMarkets.com s offering. Amid the COVID-19 crisis, the global market for In Vitro Diagnostics (IVD) Quality Control estimated at US$926.6 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027. Immunochemistry, one of the segments analyzed in the report, is projected to record a 3.7% CAGR and reach US$423.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hematology segment is readjusted to a revised 4% CAGR for the next 7-year period.

Australia
Japan
United-states
United-kingdom
Argentina
Brazil
China
Canada
Russia
Dublin
Ireland
Mexico

vimarsana © 2020. All Rights Reserved.